Santos PLA, Merlán MM

Language: Spanish
References: 16
Page: 11-18
PDF size: 149.38 Kb.

ABSTRACT

The prognosis in sepsis depends on many factors, so it is of our interest in addition to the epidemiological study of it, its value for the prediction of mortality of various severity indices. A clinical, analytical, prospective, non-interventionist study was carried out in the Intensive Care Unit, at the "Arnaldo Milian Castro" University Hospital, from January to December 2009 with the purpose of determining the value of a group of clinical and laboratory variables, and of the APACHE II, SOFA, MODS, LIS and Glasgow scales, as values for the prediction of mortality in patients with severe sepsis, septic shock, or both. 9,4 % of the patients were studied met criteria for severe sepsis. 64 % of them (32) had at least one episode of septic shock. Mortality was strongly and independently associated with the number of comorbidities and of dysfunctional organs. The scales we studied were all predictors of mortality.

REFERENCES

1. Valero Reig R. Valoración de la gravedad en la sepsis grave. REMI Rev Electrónica Med Intens [Internet]. 2005 [citado 8 nov. 2007];5(3):[aprox. 10 p.] Disponible en: http://remi.uninet.edu/2005/03/REMIC32.htm

2. Palencia HE. La sepsis: definiciones y estadios. REMI Rev Electrónica Med Intens [Internet]. 2004 [citado 8 nov. 2007];4(6):[aprox. 6 p.]. Disponible en: http://remi.uninet.edu/2004/01/REMI31.htm

3. Nin Vaeza N, Lorente Balanza JA, Ortiz-Leyba C, Valenzuela Sánchez F, Baigorri González F, López Rodríguez A, et al. Estudio multicéntrico sobre la asociación entre variables relacionadas con la resucitación y la mortalidad en la sepsis grave. Med Intens. 2005;29(4):212-8.

4. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. CORTICUS Study Group. Hydrocortisone Therapy for Patients with Septic shock. N Engl J Med. 2008;358(2):111- 24.

5. Russell JA. Management of Sepsis. N Engl J Med. 2006;355(16):1699-713.

6. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic choque D. Chest. 2009;136(5):1237-48.

7. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(10):111-24.

8. Parrillo JE. Septic shock-Vasopressin, Norepinephrine, and Urgency. N Engl J Med. 2008;358(9):954-6.

9. Dellinger RP, Charlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34:17-60.

10. The EPISEPSIS Study Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30:580-8.

11. Blanco J. Incidence of organ dysfunction and mortality in severe sepsis: a Spanish Multicenter Study. Crit Care. 2008;12(6):970-6.

12. Farreiras FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to Predict Outcome in Critically Ill patients. JAMA. 2001;236:1754-8.

13. Íñigo J, Sendra JM, Díaz R, Sarría-Santamera. Epidemiología y costes de la sepsis grave en Madrid. Estudio de altas hospitalarias. Med Intensiva. Madrid. 2006;30(5):210-5.

14. Valenzuela FS. Actualización en sepsis. Choque séptico. Med Intens. 2005;29(3):192-200.

15. Vicent JL. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):552-4.

16. Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Fernando MS, Llorca J, Delgado- Rodríguez M. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: Results of 3-year follow-up quasi-experimental study. Crit Care Med. 2010;38(4):1-8.